{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004772.4:c.1886A>G",
          "cDNA Change": {
            "transcript": "NM_004772.4",
            "ref": "A",
            "alt": "G",
            "position": "1886"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "G",
            "position": "629"
          },
          "Description in input context": "A common variant initially identified as c.1886A>G, was found to segregate with disease status."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial Parkinson's Disease",
    "MONDO": "MONDO:0003922"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial Membrane Potential Assay",
      "Material used": {
        "Material Source": "Patient-Derived Material",
        "Material Name": "Fibroblasts",
        "Description": "Experiments using patient-derived fibroblasts showed a significant reduction in mitochondrial membrane potential compared to controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004772.4:c.1886A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Patient fibroblasts showed a significant reduction in mitochondrial membrane potential compared to control fibroblasts."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were used."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition was tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type sequence was utilized as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "CRISPR knockout of *PINK1* was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 60%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 30%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Mitophagy Assay using iPSC-derived Dopaminergic Neurons",
      "Material used": {
        "Material Source": "iPSCs",
        "Material Name": "iPSC-derived Dopaminergic Neurons",
        "Description": "Experiments using induced pluripotent stem cells (iPSCs) differentiated into dopaminergic neurons, revealed impaired mitophagy."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004772.4:c.1886A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Mitophagy was impaired in iPSC-derived dopaminergic neurons carrying the PINK1 variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were used."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition was tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type sequence was utilized as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "CRISPR knockout of *PINK1* was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 60%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 30%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}